NASDAQ: IMNM - Immunome

Yield per half year: -37.85%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Immunome

Extended chart Simple chart
Financial Markets by TradingView

About Immunome

Immunome, Inc. - биофармацевтическая компания, которая занимается открытием и разработкой терапевтических препаратов на основе антител. Основное внимание уделяется онкологии и инфекционным заболеваниям. Он использует запатентованную платформу В-клеток памяти человека, чтобы сделать возможным открытие новых антител в обеих терапевтических областях благодаря опросу В-клеток памяти пациентов, которые научились бороться с этими заболеваниями. Компания была основана Скоттом К. Дессейном и Грегори П. Личолаем 2 марта 2006 года, ее штаб-квартира находится в Экстоне, штат Пенсильвания.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-10-02
ISIN US45257U1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://immunome.com
Цена ао 9.44
Change price per day: -2.43% (9.67)
Change price per week: -4.7% (9.9)
Change price per month: -2.63% (9.69)
Change price per 3 month: -29.96% (13.47)
Change price per half year: -37.85% (15.18)
Change price per year: -61.43% (24.46)
Change price per 3 year: +131.25% (4.08)
Change price per 5 year: 0% (9.435)
Change price per 10 year: 0% (9.435)
Change price per year to date: -15.08% (11.11)
All parameters

Underestimation

Title Value Grade
P/S 14.38 1
P/BV 1.68 8
P/E 0 0
EV/EBITDA -0.9612 0
Total: 4.38

Efficiency

Title Value Grade
ROA, % -71.9 0
ROE, % -89.09 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0152 10
Total: 9

Growth impulse

Title Value Grade
Yield Revenue, % 111.53 10
Yield Ebitda, % 190.47 10
Yield EPS, % 195.73 10
Total: 8
More

Institutions Volume Share, %
Avidity Partners Management, LP 874 1.46
Redmile Group, LLC 5 8.15
FMR, LLC 5 7.56
EcoR1 Capital, LLC 4 6.47
Price (T.Rowe) Associates Inc 2 3.74
Vanguard Group Inc 2 3.37
Point72 Asset Management, L.P. 2 2.74
Janus Henderson Group PLC 2 2.57
T. Rowe Price Investment Management, Inc. 2 2.53
Woodline Partners LP 1 2.2

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Clinical Trials ETF 0.73973 63.04 0.33
iShares Micro-Cap ETF 0.19545 17.09 1.54048
Direxion Daily S&P Biotech Bull 3x Shares 0.15156 4067.92 0.25924
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.07637 18.2 1.66828
Goldman Sachs Innovate Equity ETF 0.07321 29.66 1.20987
Nuveen ESG Small-Cap ETF 0.06134 13.91 1.41019
Vanguard Russell 2000 Growth ETF 0.06 23.05 0.60264
iShares Russell 2000 Growth ETF 0.05712 38.04 0.6026
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
iShares Morningstar Small-Cap Growth ETF 0.02829 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.02829 587.89 0.72598
ProShares UltraPro Russell2000 0.01664 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01413 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01413 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.00956 3 1.46057
ProShares Hedge Replication ETF 0.00488 5.92 1.47892
Humankind US Stock ETF 0.00466 18.81 1.99919
iShares Russell 3000 ETF 0.00138 24.83 1.43482
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Dr. Clay B. Siegall Ph.D. President, CEO & Chairman N/A 1961 (64 years)
Mr. Max Rosett Executive VP of Operations, Principal Accounting & Financial Officer and CFO N/A 1990 (35 years)
Dr. Jack Higgins Ph.D. Chief Scientific Officer N/A 1980 (45 years)
Ms. Sandra G. Stoneman Esq., J.D. Chief Legal Officer, General Counsel & Corporate Secretary 443.43k 1973 (52 years)
Mr. Bruce Turner M.D., Ph.D. Chief Strategy Officer N/A 1964 (61 year)
Dr. Robert J. Lechleider M.D. Chief Medical Officer N/A 1961 (64 years)
Mr. Kinney Horn Chief Business Officer N/A 1975 (50 years)
Dr. Philip Tsai Chief Technical Officer

Address: United States, Exton, PA , 665 Stockton Drive - open in Google maps, open in Yandex maps
Website: http://immunome.com